Expense Ratio Rating
5 /10
Expense Rating
0 /10
Market Score
7 /10
Category Score
5 /10
Market Size
7 /10
We found 9,682 Allocation All-In-One funds. Here they are ordered by FI Score.
First Trust NASDAQ Global Auto Index Fund
Expenses: 0.70% (Better than 0% of similar funds)
This is a bad choice for a Consumer Cyclicals Sector Equity fund. See why »
VanEck Vectors CEF Municipal Income ETF
Expenses: 1.86% (Better than 0% of similar funds)
This is a bad choice for a Municipal Bond Bond fund. See why »
ProFunds UltraShort Mid-Cap Fund Investor Class
Expenses: 1.78% (Better than 0% of similar funds)
This is a bad choice for a Inverse Alternatives fund. See why »
Victory RS Select Growth Fund Class C
Expenses: 2.18% (Better than 0% of similar funds)
This is a bad choice for a Mid-Cap Growth US Stocks fund. See why »
Rydex Precious Metals Fund Class Investor
Expenses: 1.39% (Better than 0% of similar funds)
This is a bad choice for a Basic Materials Sector Equity fund. See why »
Madison International Stock Fund Class A
Expenses: 1.60% (Better than 0% of similar funds)
This is a bad choice for a Large Blend International Stocks fund. See why »
Guggenheim StylePlus - Mid Growth Fund Class P
Expenses: 1.51% (Better than 0% of similar funds)
This is a bad choice for a Mid-Cap Growth US Stocks fund. See why »
Firsthand Technology Opportunities Fund
Expenses: 1.83% (Better than 0% of similar funds)
This is a bad choice for a Technology Sector Equity fund. See why »
Wells Fargo High Yield Municipal Bond Fund - Class C
Expenses: 1.55% (Better than 0% of similar funds)
This is a bad choice for a Municipal Bond Bond fund. See why »
ProFunds Short NASDAQ-100 Fund Investor Class
Expenses: 1.78% (Better than 0% of similar funds)
This is a bad choice for a Inverse Alternatives fund. See why »
Union Street Partners Value Fund Class A Shares
Expenses: 1.60% (Better than 0% of similar funds)
This is a bad choice for a Large Value US Stocks fund. See why »
Rydex Biotechnology Fund Class A
Expenses: 1.71% (Better than 0% of similar funds)
This is a bad choice for a Healthcare Sector Equity fund. See why »
Rydex Biotechnology Fund Class H
Expenses: 1.71% (Better than 0% of similar funds)
This is a bad choice for a Healthcare Sector Equity fund. See why »
Rydex Russell 2000 2x Strategy Fund Class C
Expenses: 2.59% (Better than 0% of similar funds)
This is a bad choice for a Leveraged Equities Alternative fund. See why »
AIG International Dividend Strategy Fund Class A
Expenses: 1.90% (Better than 0% of similar funds)
This is a bad choice for a Large Value International Stocks fund. See why »
ProShares UltraShort Health Care
Expenses: 0.95% (Better than 0% of similar funds)
This is a bad choice for a Inverse Alternative fund. See why »
Rydex Consumer Products Fund Class A
Expenses: 1.71% (Better than 0% of similar funds)
This is a bad choice for a Consumer Defensive Sector Equity fund. See why »
Leland Thomson Reuters Private Equity Buyout Index Fund Class A
Expenses: 1.75% (Better than 0% of similar funds)
This is a bad choice for a Large Blend US Stocks fund. See why »
DWS Emerging Markets Fixed Income Fund - Class A
Expenses: 1.11% (Better than 0% of similar funds)
This is a bad choice for a High Yield Bond Bond fund. See why »
Minafi - The intersection of FI, minimalism & mindfulness.
Don't miss out on new posts, courses, interactive articles and more!
Join & Get Your First Course Free© 2025 Adam Fortuna
Site Map